Everything You Need to Know About CBD Vaping

Aug.18.2022
Everything You Need to Know About CBD Vaping
CBD e-cigarettes are a popular way to consume CBD, offering potential benefits such as reduced anxiety and pain. However, it's important to understand the potential risks and talk to a doctor before using.

CBD e-cigarettes offer a way to consume cannabidiol (CBD), particularly for those seeking a smoking alternative. Using CBD e-cigarettes has potential benefits, including reducing anxiety and pain, and promoting better sleep. However, it's important to be aware of the risks associated with CBD e-cigarettes before starting. This article will explain everything you need to know about CBD e-cigarettes, including potential risks and benefits.


What is CBD vaping?


CBD e-cigarettes involve inhaling vaporized marijuana compounds through a vape device. The vaporized liquid, containing CBD and other compounds, is heated and then inhaled. Similar in appearance to traditional e-cigarettes, CBD e-cigarettes do not contain tobacco and instead are filled with CBD juice, which can be flavored or unflavored.


For those who do not wish to consume marijuana or tobacco, CBD vaping has become a popular way to consume CBD. CBD vaping is considered a healthier alternative to smoking because it does not involve burning plant material. This means there is no risk of inhaling harmful toxins produced when plant material is burned.


CBD e-liquids come in various flavors such as fruity, mint, spicy, sweet, and nutty.


How does CBD vaping work?


When you use an electronic cigarette with CBD, the THC is absorbed into your bloodstream through your lungs. This process is believed to be more effective than other methods of consuming CBD, such as ingestion or oil. The effects of using CBD e-cigarettes are typically felt within a few minutes and peak between 30 and 60 minutes later.


The effects of CBD e-cigarette oil typically last for 2 to 4 hours, although this may vary depending on a person's metabolism and other factors.


What are the potential benefits of CBD e-cigarettes?


CBD has been shown to provide a variety of potential health benefits, including reducing anxiety and pain, as well as promoting better sleep.


A 2019 study found that CBD may help lower anxiety levels in people with certain conditions such as social anxiety disorder (SAD). Participants in the study consumed 600mg of CBD oil or a placebo before giving a public speech.


A study published in 2019 investigated the effects of CBD on pain. Participants were either given 600mg of CBD or a placebo. Researchers found that the CBD group experienced significantly lower levels of pain compared to the placebo group. They also observed a decrease in inflammation levels for the CBD group.


A study in 2018 found that CBD may help improve the sleep of individuals suffering from insomnia. Participants were given a dosage of 25mg, 50mg, or 100mg of CBD before bedtime. Those who received higher doses of CBD (50mg and 100mg) reported much better sleep quality compared to those who took lower dosages (25mg) or a placebo.


What are the potential risks of CBD e-cigarettes?


CBD is generally considered safe, but there are also some risks associated with it, including lung irritation, elevated heart rate, dry mouth, dizziness, diarrhea, and fatigue.


It is equally important to realize that CBD products are not regulated by the U.S. Food and Drug Administration (FDA). This means that their safety and effectiveness cannot be guaranteed. Additionally, CBD products may contain other compounds not listed on the label.


If you are considering using CBD e-cigarette oil, it is important to first consult with your doctor. They can help you weigh the potential risks and benefits of using CBD e-cigarettes and determine if it is suitable for you.


CBD E-cigarettes: The Bottom Line.


CBD e-cigarettes have become a popular consumer choice for consuming CBD, as they are considered a healthier alternative to smoking or marijuana. CBD e-liquid comes in a variety of different flavors.


CBD has been proven to provide a range of potential health benefits, including reducing anxiety and pain, as well as promoting better sleep. However, vaping CBD carries some potential risks, such as lung irritation and increased heart rate.


If you are considering using CBD e-cigarette oil, be sure to first consult with your doctor. They can help you weigh the potential risks and benefits of CBD e-cigarettes, and determine if it is suitable for you.


Statement


This article was compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is intended solely for industry communication and research purposes.


Due to limitations in translation ability, the translated article may not fully reflect the original text. Please refer to the original article for accurate information.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign issues and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
The Irish presidency of the Council of the European Union is using bilateral talks to push the bloc’s Tobacco Taxation Directive toward a political agreement in November. According to Law360, citing an EU official, Sweden is unwilling to accept a minimum excise threshold above €20 per kilogram for nicotine pouches. Council negotiations have already lowered the European Commission’s original proposal, but a May 2026 presidency compromise still set the minimum at 10% of the tax-inclusive retail price or €30 per kilogram in 2028-29, with higher levels later.
Market
Sep.17 by 2Firsts Perspectives
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
According to Free Malaysia Today on August 26, 2026, Malaysia’s Health Minister Dzulkefly Ahmad said the Health Ministry would explain the government’s decision to withdraw its appeal against a High Court ruling involving the exemption of liquid nicotine used in vape products from the Poisons List. The High Court previously ruled that the exemption decision was irrational. Dzulkefly said withdrawing the appeal did not mean the government would stop regulating vaping, and that future regulatory approaches would continue under existing legal frameworks.
Aug.28
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04